All results
28 results for targeted therapy directed genetic testing patients advanced solid tumors
-
Clinical Trials
This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal…
-
Clinical Trials
This phase II trial tests whether ZEN003694 (ZEN-3694) in combination with talazoparib works to shrink tumors in patients with solid tumors that are unlikely…
-
Clinical TrialsTAPUR: Testing FDA Approved Drugs That Target Specific Abnormal Tumor Genes in Pts w/Advanced Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a…
-
Clinical Trials
This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and…
-
Conditions & Treatments
The UF Health Breast Center’s comprehensive medical team provides compassionate care and personalized treatment options for you and your family. We bring…
-
News, Stories & Blog
2016 was a tremendous year of continued growth and progress for UF Health. In this “year-in-review” issue of OTSP, we highlight achievements in each of the…
-
News, Stories & Blog
Part 2 of our "Year in Review" focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…
-
News, Stories & Blog
Part 2 of our “year in review” focuses on the hospitals, research institutes and centers that are part of the UF Health family. When added to the colleges…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…
-
News, Stories & Blog
2017 was a tremendous year of continued growth and progress for UF Health. In this “year-in-review” issue of OTSP, we highlight achievements in each of the…